{"id":5657,"date":"2021-09-20T15:13:51","date_gmt":"2021-09-20T12:13:51","guid":{"rendered":"https:\/\/regate.gr\/?page_id=5657"},"modified":"2021-11-29T14:12:35","modified_gmt":"2021-11-29T12:12:35","slug":"case-studies-gr","status":"publish","type":"page","link":"https:\/\/regate.gr\/case-studies-gr\/","title":{"rendered":"Case Studies"},"content":{"rendered":"
[vc_row][vc_column][vc_empty_space][vc_column_text][\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][vc_empty_space][vc_single_image image=”5349″ img_size=”200×100″ alignment=”right” onclick=”custom_link” link=”https:\/\/regate.gr\/wp-content\/uploads\/2021\/02\/CASE_STUDY_BIZEGATE_SARANTIS_SFA_MERCH-1.pdf”][vc_empty_space][\/vc_column][vc_column width=”2\/3″][vc_empty_space][vc_column_text]<\/p>\n
\n\u03a3\u0391\u03a1\u0391\u039d\u03a4\u0397\u03a3 \u0391.\u0392.\u0395.\u0395.<\/span><\/h3>\n\n | JOHNSON & JOHNSON \u0395\u039b\u039b\u0391\u03a3 \u0391.\u0395.\u0392.\u0395.<\/span><\/h3>\n\n | \u039a\u039f\u03a5\u03a6\u0395\u03a4\u039f\u03a0\u039f\u0399\u0399\u0391 \u03a7\u0391\u03a4\u0396\u0397\u0393\u0399\u0391\u039d\u039d\u0391\u039a\u0397 \u0391.\u0395.<\/span><\/h3>\n\n | \u039c\u03a5\u039b\u039f\u0399 \u039a\u03a1\u0397\u03a4\u0397\u03a3 \u0391.\u0395.<\/span><\/h3>\n\n | GREENCOLA \u0391.\u0395.<\/span><\/h3>\n\n | \u0395\u0396\u0391 \u0391.\u0395.<\/span><\/h3>\n\n | \u0395\u03a8\u0391 \u0391.\u0395.<\/span><\/h3>\n\n | RELKON HELLAS \u0391.\u0395.<\/span><\/h3>\n\n | RESOUL \u0391.\u0395.<\/span><\/h3>\n\n | COSMOSLAC A.E.<\/span><\/h3>\n\n | WEST A.E.<\/span><\/h3>\n\n | \u039f\u039b\u03a5\u039c\u03a0\u0399\u0391\u039aH \u0396\u03a5\u0398\u039f\u03a0\u039f\u0399I\u0391 A.\u0395.<\/span><\/h3>\n\n | PFIZER HELLAS A.E.<\/span><\/h3>\n\n | PURATOS HELLAS \u0391\u0395BE<\/span><\/h3>\n\n | BRADEX \u0391.\u0395.<\/span><\/h3>\n\n | JANSSEN CILAG A.E.<\/span><\/h3>\n\n | ACTMEDIA A.E.<\/span><\/h3>\n\n | WIND HELLAS<\/span><\/h3>\n\n | \u0398\u0395\u0391\u039d\u03a9 \u0395\u039c\u03a0\u039f\u03a1\u0399\u039a\u0397 \u0395\u03a0\u0395<\/span><\/h3>\n\n | OVERVALUE A.E.<\/span><\/h3>\n\n | FARMECO A.E.<\/span><\/h3>\n\n | \u039c\u0395\u03a4\u03a1\u0399\u0394\u0397\u03a3 A.E.<\/span><\/h3>\n\n | \u0391\u039d\u0391\u03a4\u03a3 A.E.<\/span><\/h3>\n\n | \u0393\u039f\u03a5\u0392\u0391\u039b\u0397\u03a3 A.E.<\/span><\/h3>\n\n | COLOMER GROUP HELLAS A.E.<\/span><\/h3>\n\n | NOVAPHARM A.E.<\/span><\/h3>\n |